Cell-Based Ophthalmic Therapies Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Cell-Based Ophthalmic Therapies Market Report 2026

Name: Cell-Based Ophthalmic Therapies Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Therapy Type (Stem Cell Therapy, Gene Therapy, Tissue Engineering), By Application (Retinal Disorders, Corneal Disorders, Glaucoma, Other Applications), By End-User (Hospitals, Ophthalmic Clinics, Research Institutes, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Cell-Based Ophthalmic Therapies Market Overview

• Cell-Based Ophthalmic Therapies market size has reached to $1.48 billion in 2025

• Expected to grow to $3.78 billion in 2030 at a compound annual growth rate (CAGR) of 20.5%

• Growth Driver: Increasing Prevalence Of Ophthalmic Disorders Fueling The Growth Of The Market Due To Rising Vision Impairment Burden

• Market Trend: Breakthrough Allogeneic cell therapy Advances Treatment For Corneal Endothelial Diseases

• North America was the largest region in 2025.

What Is Covered Under Cell-Based Ophthalmic Therapies Market?

Cell-based ophthalmic therapies are treatments for eye diseases that use living cells to repair, replace, or protect damaged ocular tissues. They target eye conditions that are difficult to treat with conventional methods by encouraging tissue repair and improving eye function. They provide promising, lasting solutions for vision impairment and enhance patients’ eyesight and overall quality of life through innovative regenerative medicine.

The main types of cell-based ophthalmic therapies are stem cell therapy, gene therapy, and tissue engineering. Stem cell therapy is a medical treatment that uses stem cells to repair, replace, or regenerate damaged or diseased tissues and organs in the body. It is used in various applications such as retinal disorders, corneal disorders, glaucoma, and others, and also used by various end users such as hospitals, ophthalmic clinics, research institutes, and others.

Cell-Based Ophthalmic Therapies Market Global Report 2026 Market Report bar graph

What Is The Cell-Based Ophthalmic Therapies Market Size and Share 2026?

The cell-based ophthalmic therapies market size has grown exponentially in recent years. It will grow from $1.48 billion in 2025 to $1.79 billion in 2026 at a compound annual growth rate (CAGR) of 20.9%. The growth in the historic period can be attributed to limited treatment options for degenerative eye diseases, growing prevalence of retinal and corneal disorders, increasing aging population, rising awareness of regenerative medicine, expansion of ophthalmic research infrastructure.

What Is The Cell-Based Ophthalmic Therapies Market Growth Forecast?

The cell-based ophthalmic therapies market size is expected to see exponential growth in the next few years. It will grow to $3.78 billion in 2030 at a compound annual growth rate (CAGR) of 20.5%. The growth in the forecast period can be attributed to advancements in stem cell and gene editing technologies, increasing investment in regenerative ophthalmology, rising regulatory approvals for cell-based therapies, growing demand for long-term vision restoration solutions, expansion of specialized ophthalmic treatment centers. Major trends in the forecast period include increasing adoption of stem cell and gene therapies for vision restoration, rising focus on regenerative treatments for retinal and corneal disorders, growth in clinical trials for cell-based ophthalmic therapies, expansion of personalized and precision ophthalmic treatments, improved long-term outcomes compared to conventional ophthalmic therapies.

Book your 30 minutes free consultation with our research experts

Global Cell-Based Ophthalmic Therapies Market Segmentation

1) By Therapy Type: Stem Cell Therapy, Gene Therapy, Tissue Engineering

2) By Application: Retinal Disorders, Corneal Disorders, Glaucoma, Other Applications

3) By End-User: Hospitals, Ophthalmic Clinics, Research Institutes, Other End-Users

Subsegments:

1) By Stem Cell Therapy: Embryonic Stem Cell Therapy, Mesenchymal Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, Retinal Pigment Epithelium Cell Therapy, Limbal Stem Cell Therapy

2) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Vector Based Gene Therapy, In-Vivo Gene Therapy, Ex-Vivo Gene Therapy, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Based Gene Therapy

3) By Tissue Engineering: Bioengineered Corneal Tissue, Amniotic Membrane Transplantation, Hydrogel-Based Scaffolds, Synthetic Polymer Scaffolds, Decellularized Tissue Constructs

What Is The Driver Of The Cell-Based Ophthalmic Therapies Market?

The increasing prevalence of ophthalmic disorders is expected to propel the growth of the cell-based ophthalmic therapies market going forward. Ophthalmic disorders refer to diseases or conditions impacting the eyes, that create vision problems or damage to eye health. Ophthalmic disorders are on the rise as the aging population faces a greater risk of age-related eye diseases, resulting to vision impairment with longer life expectancy. Cell-based ophthalmic therapies repair or replace damaged retinal and eye cells to restore vision and prevent further damage while promoting regeneration and enhancing overall eye function. For instance, in August 2024, according to the Welsh Government, a UK-based government agency, ophthalmology departments in Wales recorded over 35,000 admissions in 2023-24, marking a 5.8% increase from 2022-2023. Therefore, the increasing prevalence of ophthalmic disorders is driving the growth of the cell-based ophthalmic therapies industry.

Key Players In The Global Cell-Based Ophthalmic Therapies Market

Major companies operating in the cell-based ophthalmic therapies market are F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Astellas Pharma Inc., Sumitomo Pharma Co. Ltd., Healios K.K., Lineage Cell Therapeutics, Pandorum Technologies Pvt. Ltd., Neurotech Pharmaceuticals Inc., Coave Therapeutics SAS, jCyte Inc., Eyestem Research Pvt. Ltd., Opsis Therapeutics, Regenerative Patch Technologies LLC, Emmetrope Ophthalmics LLC, GenSight Biologics S.A., MEDIPOST Co. Ltd., Riken, Luxa Biotechnology Inc.

Global Cell-Based Ophthalmic Therapies Market Trends and Insights

Major companies operating in the cell-based ophthalmic therapies market are focusing on developing advanced treatments, such as allogeneic cell therapy, to address unmet needs in treating corneal endothelial diseases. Allogeneic cell therapy refers to a treatment that uses stem cells or other cells donated by a genetically different individual of the same species to repair or replace damaged tissues or treat diseases. For instance, in September 2024, Aurion Biotech, Inc., a US-based clinical-stage biotechnology company, announced the commercial launch of Vyznova (neltependocel) in Japan. It is designed for the treatment of bullous keratopathy, a debilitating condition of the corneal endothelium. Vyznova is believed to be the first approved allogeneic cell therapy specifically targeting corneal endothelial disease, having secured both regulatory and reimbursement approvals in Japan.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Cell-Based Ophthalmic Therapies Market?

In March 2025, Alcon Inc., a Switzerland-based eye care company, acquired a majority interest in Aurion Biotech, Inc. for an undisclosed amount. With this acquisition, Alcon aims to advance Aurion Biotech’s clinical-stage allogeneic cell therapy, AURN001, into Phase 3 development for treating corneal edema secondary to corneal endothelial disease, while expanding its ophthalmic pharmaceutical portfolio. Aurion Biotech Inc. is a US-based clinical-stage company developing advanced cell therapies to treat eye diseases.

Regional Insights

North America was the largest region in the cell-based ophthalmic therapies market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cell-Based Ophthalmic Therapies Market?

The cell-based ophthalmic therapies market consists of revenues earned by entities by providing services such as clinical trial services, ocular cell therapy consultation, post-therapy monitoring and support, research and development services, and regulatory and compliance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell-based ophthalmic therapies market also includes sales of neural progenitor cell injections, bioengineered retinal pigment epithelium scaffolds, autologous mesenchymal stem cell grafts, and ex-vivo expanded conjunctival epithelial cell sheets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cell-Based Ophthalmic Therapies Market Report 2026?

The cell-based ophthalmic therapies market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cell-based ophthalmic therapies industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Cell-Based Ophthalmic Therapies Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$1.79 billion
Revenue Forecast In 2035	$3.78 billion
Growth Rate	CAGR of 20.9% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Therapy Type, Application, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Astellas Pharma Inc., Sumitomo Pharma Co. Ltd., Healios K.K., Lineage Cell Therapeutics, Pandorum Technologies Pvt. Ltd., Neurotech Pharmaceuticals Inc., Coave Therapeutics SAS, jCyte Inc., Eyestem Resear
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Cell-Based Ophthalmic Therapies Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Cell-Based Ophthalmic Therapies Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Cell-Based Ophthalmic Therapies Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Cell-Based Ophthalmic Therapies Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Stem Cell And Gene Therapies For Vision Restoration

4.2.2 Rising Focus On Regenerative Treatments For Retinal And Corneal Disorders

4.2.3 Growth In Clinical Trials For Cell-Based Ophthalmic Therapies

4.2.4 Expansion Of Personalized And Precision Ophthalmic Treatments

4.2.5 Improved Long-Term Outcomes Compared To Conventional Ophthalmic Therapies

5. Cell-Based Ophthalmic Therapies Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Ophthalmic Clinics

5.3 Research Institutes

5.4 Specialty Eye Centers

5.5 Academic Medical Centers

6. Cell-Based Ophthalmic Therapies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cell-Based Ophthalmic Therapies Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Cell-Based Ophthalmic Therapies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Cell-Based Ophthalmic Therapies Market Size, Comparisons And Growth Rate Analysis

7.3. Global Cell-Based Ophthalmic Therapies Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Cell-Based Ophthalmic Therapies Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cell-Based Ophthalmic Therapies Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cell-Based Ophthalmic Therapies Market Segmentation

9.1. Global Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Stem Cell Therapy, Gene Therapy, Tissue Engineering

9.2. Global Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Retinal Disorders, Corneal Disorders, Glaucoma, Other Applications

9.3. Global Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Ophthalmic Clinics, Research Institutes, Other End-Users

9.4. Global Cell-Based Ophthalmic Therapies Market, Sub-Segmentation Of Stem Cell Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Embryonic Stem Cell Therapy, Mesenchymal Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, Retinal Pigment Epithelium Cell Therapy, Limbal Stem Cell Therapy

9.5. Global Cell-Based Ophthalmic Therapies Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Viral Vector-Based Gene Therapy, Non-Viral Vector Based Gene Therapy, In-Vivo Gene Therapy, Ex-Vivo Gene Therapy, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Based Gene Therapy

9.6. Global Cell-Based Ophthalmic Therapies Market, Sub-Segmentation Of Tissue Engineering, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Bioengineered Corneal Tissue, Amniotic Membrane Transplantation, Hydrogel-Based Scaffolds, Synthetic Polymer Scaffolds, Decellularized Tissue Constructs

10. Cell-Based Ophthalmic Therapies Market Regional And Country Analysis

10.1. Global Cell-Based Ophthalmic Therapies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Cell-Based Ophthalmic Therapies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cell-Based Ophthalmic Therapies Market

11.1. Asia-Pacific Cell-Based Ophthalmic Therapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cell-Based Ophthalmic Therapies Market

12.1. China Cell-Based Ophthalmic Therapies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cell-Based Ophthalmic Therapies Market

13.1. India Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cell-Based Ophthalmic Therapies Market

14.1. Japan Cell-Based Ophthalmic Therapies Market Overview

14.2. Japan Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cell-Based Ophthalmic Therapies Market

15.1. Australia Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cell-Based Ophthalmic Therapies Market

16.1. Indonesia Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cell-Based Ophthalmic Therapies Market

17.1. South Korea Cell-Based Ophthalmic Therapies Market Overview

17.2. South Korea Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cell-Based Ophthalmic Therapies Market

18.1. Taiwan Cell-Based Ophthalmic Therapies Market Overview

18.2. Taiwan Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cell-Based Ophthalmic Therapies Market

19.1. South East Asia Cell-Based Ophthalmic Therapies Market Overview

19.2. South East Asia Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cell-Based Ophthalmic Therapies Market

20.1. Western Europe Cell-Based Ophthalmic Therapies Market Overview

20.2. Western Europe Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cell-Based Ophthalmic Therapies Market

21.1. UK Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cell-Based Ophthalmic Therapies Market

22.1. Germany Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cell-Based Ophthalmic Therapies Market

23.1. France Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cell-Based Ophthalmic Therapies Market

24.1. Italy Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cell-Based Ophthalmic Therapies Market

25.1. Spain Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cell-Based Ophthalmic Therapies Market

26.1. Eastern Europe Cell-Based Ophthalmic Therapies Market Overview

26.2. Eastern Europe Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cell-Based Ophthalmic Therapies Market

27.1. Russia Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cell-Based Ophthalmic Therapies Market

28.1. North America Cell-Based Ophthalmic Therapies Market Overview

28.2. North America Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cell-Based Ophthalmic Therapies Market

29.1. USA Cell-Based Ophthalmic Therapies Market Overview

29.2. USA Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cell-Based Ophthalmic Therapies Market

30.1. Canada Cell-Based Ophthalmic Therapies Market Overview

30.2. Canada Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cell-Based Ophthalmic Therapies Market

31.1. South America Cell-Based Ophthalmic Therapies Market Overview

31.2. South America Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cell-Based Ophthalmic Therapies Market

32.1. Brazil Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cell-Based Ophthalmic Therapies Market

33.1. Middle East Cell-Based Ophthalmic Therapies Market Overview

33.2. Middle East Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cell-Based Ophthalmic Therapies Market

34.1. Africa Cell-Based Ophthalmic Therapies Market Overview

34.2. Africa Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cell-Based Ophthalmic Therapies Market Regulatory and Investment Landscape

36. Cell-Based Ophthalmic Therapies Market Competitive Landscape And Company Profiles

36.1. Cell-Based Ophthalmic Therapies Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Cell-Based Ophthalmic Therapies Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Cell-Based Ophthalmic Therapies Market Company Profiles

36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Sumitomo Pharma Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Cell-Based Ophthalmic Therapies Market Other Major And Innovative Companies

Healios K.K., Lineage Cell Therapeutics, Pandorum Technologies Pvt. Ltd., Neurotech Pharmaceuticals Inc., Coave Therapeutics SAS, jCyte Inc., Eyestem Research Pvt. Ltd., Opsis Therapeutics, Regenerative Patch Technologies LLC, Emmetrope Ophthalmics LLC, GenSight Biologics S.A., MEDIPOST Co. Ltd., Riken, Luxa Biotechnology Inc.

38. Global Cell-Based Ophthalmic Therapies Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cell-Based Ophthalmic Therapies Market

40. Cell-Based Ophthalmic Therapies Market High Potential Countries, Segments and Strategies

40.1 Cell-Based Ophthalmic Therapies Market In 2030 - Countries Offering Most New Opportunities

40.2 Cell-Based Ophthalmic Therapies Market In 2030 - Segments Offering Most New Opportunities

40.3 Cell-Based Ophthalmic Therapies Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Cell-Based Ophthalmic Therapies Market, Overview Of Key Products - Product Examples

Table 2: Global Cell-Based Ophthalmic Therapies Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Cell-Based Ophthalmic Therapies Market, Supply Chain Analysis

Table 4: Global Cell-Based Ophthalmic Therapies Market, Major Raw Material Providers

Table 5: Global Cell-Based Ophthalmic Therapies Market, Major Resource Providers

Table 6: Global Cell-Based Ophthalmic Therapies Market, Major Manufacturers (Suppliers)

Table 7: Global Cell-Based Ophthalmic Therapies Market, Major Distributors And Channel Partners

Table 8: Global Cell-Based Ophthalmic Therapies Market, Key Technologies & Future Trends

Table 9: Global Cell-Based Ophthalmic Therapies Market, Major Trends

Table 10: Global Cell-Based Ophthalmic Therapies Market, Major End Users

Table 11: Global Cell-Based Ophthalmic Therapies Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Cell-Based Ophthalmic Therapies Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Cell-Based Ophthalmic Therapies Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Cell-Based Ophthalmic Therapies Market - TAM, US$ Billion, 2025

Table 15: Global Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Cell-Based Ophthalmic Therapies Market, Sub-Segmentation Of Stem Cell Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Cell-Based Ophthalmic Therapies Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Cell-Based Ophthalmic Therapies Market, Sub-Segmentation Of Tissue Engineering, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Cell-Based Ophthalmic Therapies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Cell-Based Ophthalmic Therapies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Global Cell-Based Ophthalmic Therapies Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 96: Global Cell-Based Ophthalmic Therapies Market - Company Scoring Matrix

Table 97: F. Hoffmann-La Roche Ltd. Financial Performance

Table 98: Bayer AG Financial Performance

Table 99: Novartis AG Financial Performance

Table 100: Astellas Pharma Inc. Financial Performance

Table 101: Sumitomo Pharma Co. Ltd. Financial Performance

Table 102: Global Cell-Based Ophthalmic Therapies Market, Competitive Benchmarking (In USD Billions)

Table 103: Global Cell-Based Ophthalmic Therapies Market, Competitive Dashboard

Table 104: Global Cell-Based Ophthalmic Therapies Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 105: Global, Cell-Based Ophthalmic Therapies Market Size Gain ($ Billion), Segmentation By Therapy Type, 2025 – 2030

Table 106: Global, Cell-Based Ophthalmic Therapies Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Table 107: Global, Cell-Based Ophthalmic Therapies Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

Figure 1: Global Cell-Based Ophthalmic Therapies Market, Overview Of Key Products - Product Examples

Figure 2: Global Cell-Based Ophthalmic Therapies Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Cell-Based Ophthalmic Therapies Market, Supply Chain Analysis

Figure 4: Global Cell-Based Ophthalmic Therapies Market, Major Raw Material Providers

Figure 5: Global Cell-Based Ophthalmic Therapies Market, Major Resource Providers

Figure 6: Global Cell-Based Ophthalmic Therapies Market, Major Manufacturers (Suppliers)

Figure 7: Global Cell-Based Ophthalmic Therapies Market, Major Distributors And Channel Partners

Figure 8: Global Cell-Based Ophthalmic Therapies Market, Key Technologies & Future Trends

Figure 9: Global Cell-Based Ophthalmic Therapies Market, Major Trends

Figure 10: Global Cell-Based Ophthalmic Therapies Market, Major End Users

Figure 11: Global Cell-Based Ophthalmic Therapies Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Cell-Based Ophthalmic Therapies Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Cell-Based Ophthalmic Therapies Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Cell-Based Ophthalmic Therapies Market - TAM, US$ Billion, 2025

Figure 15: Global Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Cell-Based Ophthalmic Therapies Market, Sub-Segmentation Of Stem Cell Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Cell-Based Ophthalmic Therapies Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Cell-Based Ophthalmic Therapies Market, Sub-Segmentation Of Tissue Engineering, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Cell-Based Ophthalmic Therapies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Cell-Based Ophthalmic Therapies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Global Cell-Based Ophthalmic Therapies Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 96: Global Cell-Based Ophthalmic Therapies Market - Company Scoring Matrix

Figure 97: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 98: Bayer AG Financial Performance

Figure 99: Novartis AG Financial Performance

Figure 100: Astellas Pharma Inc. Financial Performance

Figure 101: Sumitomo Pharma Co. Ltd. Financial Performance

Figure 102: Global Cell-Based Ophthalmic Therapies Market, Competitive Benchmarking (In USD Billions)

Figure 103: Global Cell-Based Ophthalmic Therapies Market, Competitive Dashboard

Figure 104: Global Cell-Based Ophthalmic Therapies Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 105: Global, Cell-Based Ophthalmic Therapies Market Size Gain ($ Billion), Segmentation By Therapy Type, 2025 – 2030

Figure 106: Global, Cell-Based Ophthalmic Therapies Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Figure 107: Global, Cell-Based Ophthalmic Therapies Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Specialty Breathable Membranes Market Report 2026 - Global Outlook – By Type (Polyurethane, Polytetrafluoroethylene (PTFE), Thermoplastic Polyester, Thermoplastic Elastomers, Polyether Block Amide, Copolyamide), By Distr...

Vacuum Insulation Market Report 2026 - Global Outlook – By Type (Flat Panel, Special Shape Panel), By Raw Material (Plastics, Metals), By Core Material (Silica, Fiberglass, Other Core Materials), By End-User Industry (Co...

Cold Insulation Market Report 2026 - Global Outlook – By Material Type (Fiber Glass, Polyurethane Foam, Polystyrene Foam, Phenolic Foam, Other Materials), By Insulation Type (Fibrous, Cellular), By End-Use Industry Type ...

Insulation Products Market Report 2026 - Global Outlook – By Insulation Type (Thermal, Acoustic, Other Insulation Types), By Material Type (Mineral Wool, Fiberglass, Stone Wool, Polyurethane Foam, Flexible Elastomeric Fo...

Tank Insulation Market Report 2026 - Global Outlook – By Type (Storage Tank Insulation, Transportation Tank Insulation), By Material (Polyurethane (PU) And Polyisocyanurate (PIR), Rockwool, Fiberglass, Elastomeric Foam, ...

Gas Separation Membrane Market Report 2026 - Global Outlook – By Product Type (Polyimide And Polyaramid, Polysulfone, Cellulose Acetate, Other Products), By Module (Hollow Fiber, Spiral Wound, Plate And Frame, Other Modu...

Technical Insulation Market Report 2026 - Global Outlook – By Product (Flexible Foam, Rigid Foam, Man-made Mineral Fiber ), By Application (Heating & Plumbing, HVAC, Refrigeration, Industrial Processes), By End User (Ind...

Frequently Asked Questions

How big is the Cell-Based Ophthalmic Therapies Market?

The Cell-Based Ophthalmic Therapies market was valued at $1.48 billion in 2025, increased to $1.79 billion in 2026, and is projected to reach $3.78 billion by 2030.

What is the Cell-Based Ophthalmic Therapies market growth?

The global Cell-Based Ophthalmic Therapies market is expected to grow at a CAGR of 20.5% from 2026 to 2035 to reach $3.78 billion by 2035.

Who are the key players in Cell-Based Ophthalmic Therapies market?

Some Key Players in the Cell-Based Ophthalmic Therapies market Include, F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Astellas Pharma Inc., Sumitomo Pharma Co. Ltd., Healios K.K., Lineage Cell Therapeutics, Pandorum Technologies Pvt. Ltd., Neurotech Pharmaceuticals Inc., Coave Therapeutics SAS, jCyte Inc., Eyestem Research Pvt. Ltd., Opsis Therapeutics, Regenerative Patch Technologies LLC, Emmetrope Ophthalmics LLC, GenSight Biologics S.A., MEDIPOST Co. Ltd., Riken, Luxa Biotechnology Inc. .

What is the anticipated growth trend for the Cell-Based Ophthalmic Therapies market?

Major trend in this market includes: Breakthrough Allogeneic Cell Therapy Advances Treatment For Corneal Endothelial Diseases. For further insights on this market. request a sample here

Which region has the most growth potential in the Cell-Based Ophthalmic Therapies market?

North America was the largest region in the cell-based ophthalmic therapies market in 2025. The regions covered in the cell-based ophthalmic therapies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.